Mark Andrews
19Patents
4h-index
45Co-inventors
60Inventor score
Filing activity: Mar 16, 2001 → Dec 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6630504B2 | Phenoxyphenylheterocyclyl derivatives as SSRIs | Chemistry; Metallurgy | 43 | Expired |
| US7378436B2 | Compounds | Human Necessities | 39 | Expired |
| US6448293B1 | Diphenyl ether compounds useful in therapy | Chemistry; Metallurgy | 21 | Expired |
| US8846698B2 | Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US11292799B2 | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | Human Necessities | 4 | Active |
| US11384096B2 | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 4 | Active |
| US6610747B2 | Phenoxybenzylamine derivatives as SSRIs | Chemistry; Metallurgy | 2 | Expired |
| US6800652B2 | Diaryl compounds | Chemistry; Metallurgy | 1 | Expired |
| US7736534B2 | Phosphorescent compositions and organic light emitting devices containing them | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7129234B2 | Phenyl heterocyclyl ethers | Chemistry; Metallurgy | 1 | Expired |
| US11981681B2 | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 1 | Active |
| US9163021B2 | Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors | Human Necessities | 1 | Active |
| US8883321B2 | Polymerizable compositions and organic light-emitting devices containing them | Emerging Cross-Sectional Technologies | 0 | Active |
| US12065429B2 | Small molecule modulators of IL-17 | Chemistry; Metallurgy | 0 | Active |
| US7829203B2 | Polymerisable compositions and organic light-emitting devices containing them | Emerging Cross-Sectional Technologies | 0 | Active |
| US7928099B2 | Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists | Human Necessities | 0 | Active |
| US8138188B2 | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | Human Necessities | 0 | Active |
| US8592403B2 | Diazepine and diazocane compounds as MC4 agonists | Chemistry; Metallurgy | 0 | Active |
| US11377425B1 | Small molecule modulators of IL-17 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.